{"content":"<li class=\"n-box-item date-title\" data-end=\"1464753599\" data-start=\"1464667200\" data-txt=\"Sunday, December 22, 2019\">Tuesday, May 31, 2016</li><li class=\"n-box-item sa-box-item\" data-id=\"3186499\" data-ts=\"1464735942\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JRJC\" target=\"_blank\">JRJC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186499-china-finance-online-swings-to-q1-profit-on-revenue-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China Finance Online swings to Q1 profit on revenue growth</a></h4><ul>   <li>China Finance Online (<a href=\"https://seekingalpha.com/symbol/JRJC\" title=\"China Finance Online Co. Limited\">JRJC</a> <font color=\"red\">-3.8%</font>) has arrested an after hours slide, now <font color=\"red\">down just 1.1%</font>, following a <a href=\"https://seekingalpha.com/news/3186490-china-finance-online-reports-q1-results\" target=\"_blank\">Q1 earnings report</a> where it swung to a profit after revenues more than doubled.</li>    <li>Gross margin grew to 84.3% from the prior year's 75%. The company said its iTouGu (social-driven stock selection platform) continued steady growth, now with 4.4M activated users.</li>    <li>Revenue breakout: Financial services, $26.8M (up 182%); Financial Information and Advisory, $3.2M (up 46.3%) Advertising, $0.6M (down 70.8%).</li>    <li>Cash and equivalents at quarter's end were $89.7M, up from Q4's $85.7M.</li>    <li>\n<a href=\"http://ir.chinafinanceonline.com/phoenix.zhtml?p=irol-eventDetails&amp;c=183451&amp;eventID=5228875\" target=\"_blank\">Conference call</a> to come at 8 p.m. ET.</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3186499\" data-linked=\"China Finance Online swings to Q1 profit on revenue growth\" data-tweet=\"$JRJC - China Finance Online swings to Q1 profit on revenue growth https://seekingalpha.com/news/3186499-china-finance-online-swings-to-q1-profit-on-revenue-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3186499-china-finance-online-swings-to-q1-profit-on-revenue-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186485\" data-ts=\"1464730646\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186485-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/JMEI' title='Jumei International Holding Limited'>JMEI</a> <font color='green'>+30.0%</font>. <a href='https://seekingalpha.com/symbol/IBN' title='ICICI Bank Ltd.'>IBN</a> <font color='green'>+23.6%</font>. <a href='https://seekingalpha.com/symbol/YNDX' title='Yandex N.V.'>YNDX</a> <font color='green'>+18.2%</font>. <a href='https://seekingalpha.com/symbol/GWPH' title='GW Pharmaceuticals plc'>GWPH</a> <font color='green'>+5.8%</font>. <a href='https://seekingalpha.com/symbol/ZOES' title='Zoe&#39;s Kitchen'>ZOES</a> <font color='green'>+5.2%.</font></li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/MGA' title='Magna International Inc.'>MGA</a> <font color='red'>-10.1%</font>. <a href='https://seekingalpha.com/symbol/ADPT' title='Adeptus Health'>ADPT</a> <font color='red'>-8.5%</font>. <a href='https://seekingalpha.com/symbol/ASNA' title='Ascena Retail Group Inc'>ASNA</a> <font color='red'>-5.8%</font>. <a href='https://seekingalpha.com/symbol/JRJC' title='China Finance Online Co. Limited'>JRJC</a> <font color='red'>-5.5%</font>. <a href='https://seekingalpha.com/symbol/CLLS' title='Cellectis S.A.'>CLLS</a> <font color='red'>-5.1%</font></li> </ul><div class=\"tiny-share-widget\" data-id=\"3186485\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$JMEI $IBN $YNDX - After Hours Gainers / Losers https://seekingalpha.com/news/3186485-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3186485-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186477\" data-ts=\"1464728950\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADPT\" target=\"_blank\">ADPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186477-adeptus-health-commences-exit-enabling-equity-offering-for-certain-executives-directors-and\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Adeptus Health commences exit-enabling equity offering for certain executives, directors and an institutional investor; shares off 7% after hours</a></h4><ul>\n<li>Adeptus Health (NYSE:<a href=\"https://seekingalpha.com/symbol/ADPT\" title=\"Adeptus Health\">ADPT</a>) initiates a public offering of 2.75M Class A common shares, consisting of 1,843,162 to be sold by the company and 906,838 by an affiliate of institutional stockholder Sterling Partners. Net proceeds will fund the purchase of 1,843,162 limited liability units of direct subsidiary Adeptus Health LLC held by some investors, including certain directors and executives. The company will receive no proceeds from the offering.</li>\n<li>Underwriters over-allotment is an additional 412.5K Class A shares. Price and terms have yet to be announced.</li>\n<li>Shares are down <font color=\"red\">7%</font> after hours on light volume.</li>\n<li>\n<strong>Update</strong>: The offering has been adjusted to 2.45M shares of which 1,543,162 will be sold by the company. The offering price is $62. Underwriters over-allotment is an additional 367.5K shares. Closing date is June 8. Yesterday's close was $62.24.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3186477\" data-linked=\"Adeptus Health commences exit-enabling equity offering for certain executives, directors and an institutional investor; shares off 7% after hours\" data-tweet=\"$ADPT $ADPT-RETIRED - Adeptus Health commences exit-enabling equity offering for certain executives, directors and an institutional investor; shares off 7% after hours https://seekingalpha.com/news/3186477-adeptus-health-commences-exit-enabling-equity-offering-for-certain-executives-directors-and?source=tweet\" data-url=\"https://seekingalpha.com/news/3186477-adeptus-health-commences-exit-enabling-equity-offering-for-certain-executives-directors-and\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186475\" data-ts=\"1464728897\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFTBY\" target=\"_blank\">SFTBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186475-alibabaminus-2-softbank-says-will-sell-7_9b-worth-of-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alibaba -2% as SoftBank says it will sell $7.9B worth of shares</a></h4><ul>   <li>SoftBank (<a href=\"https://seekingalpha.com/symbol/SFTBY\" title=\"SoftBank Group ADR\">OTCPK:SFTBY</a>) says it will sell <a href=\"http://www.softbank.jp/en/corp/news/press/sb/2016/20160601_02/\" target=\"_blank\">at least $7.9B worth</a> of its stake in Alibaba (NYSE:<a href=\"https://seekingalpha.com/symbol/BABA\" title=\"Alibaba Group Holding Limited\">BABA</a>) as part of a series of capital-raising transactions.</li>    <li>Alibaba shares are <font color=\"red\">2% lower</font> in after-hours trading on the NYSE.</li>    <li>Specifically, SoftBank says, it will sell $2B in ordinary shares back to Alibaba; sell $400M worth to members of the Alibaba Partnership and $500M to a \"major sovereign wealth fund\"; and use a newly formed trust to offer $5B of mandatory exchangeable trust securities, exchangeable into ADS of Alibaba, to qualified institutional buyers in private placement.</li>    <li>SoftBank will increase its liquidity cushion with the moves, it says.</li>\n<li>Afterward, it expects to continue to hold about 28% of outstanding Alibaba shares.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3186475\" data-linked=\"Alibaba -2% as SoftBank says it will sell $7.9B worth of shares\" data-tweet=\"$SFTBY $SFTBY $BABA - Alibaba -2% as SoftBank says it will sell $7.9B worth of shares https://seekingalpha.com/news/3186475-alibabaminus-2-softbank-says-will-sell-7_9b-worth-of-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3186475-alibabaminus-2-softbank-says-will-sell-7_9b-worth-of-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>54&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186470\" data-ts=\"1464728314\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UAA\" target=\"_blank\">UAA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186470-under-armour-issues-warning-due-to-sports-authoritys-bankruptcy-shares-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Under Armour issues warning due to Sports Authority&#39;s bankruptcy; shares lower</a></h4><ul>\n<li>Citing The Sports Authority's bankruptcy filing and planned asset liquidation, Under Armour (NYSE:<a href=\"https://seekingalpha.com/symbol/UA\" title=\"Under Armour, Inc. Class C\">UA</a>) now expects 2016 revenue of $4.925B (+24% Y/Y), below prior guidance of $5B and a $5.03B consensus. 2016 op. income guidance has been cut to $440M-$445M from $503M-$507M. The company notes it was \"only able to recognize $43 million of the originally planned $163 million in revenues with The Sports Authority for 2016.\"</li>\n<li>Q2 revenue is still expected to be up by a high-20s % Y/Y. However, due to a $23M impairment charge related to The Sports Authority, op. income guidance has been cut to $17M-$19M.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/UA\" title=\"Under Armour, Inc. Class C\">UA</a> <font color=\"red\">-3% </font>after hours to $36.60.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3186470\" data-linked=\"Under Armour issues warning due to Sports Authority&#39;s bankruptcy; shares lower\" data-tweet=\"$UAA - Under Armour issues warning due to Sports Authority&#39;s bankruptcy; shares lower https://seekingalpha.com/news/3186470-under-armour-issues-warning-due-to-sports-authoritys-bankruptcy-shares-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3186470-under-armour-issues-warning-due-to-sports-authoritys-bankruptcy-shares-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>67&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186461\" data-ts=\"1464726507\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDAY\" target=\"_blank\">WDAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186461-workday-slumps-in-spite-of-solid-results-guidance-unearned-revenue-up-42\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Workday slumps in spite of solid results/guidance; unearned revenue up 42%</a></h4><ul>\n<li>With shares up sharply from their February lows going into earnings, investors are in profit-taking mode (for now, at least) after Workday (NYSE:<a href=\"https://seekingalpha.com/symbol/WDAY\" title=\"Workday\">WDAY</a>) beat FQ1 estimates and offered slightly above-consensus FQ2 sales guidance. The stock is currently <font color=\"red\">down 3.9%</font> after hours to $72.85.</li>\n<li>FQ1 top-line metrics are solid: Cloud app subscription revenue rose 39% Y/Y to $280M, and professional services revenue grew 31% to $65.4M. The unearned revenue balance rose 42% to $926.1M, a growth rate on par with FQ4's in spite of a slowdown in revenue growth to 38% from 43%.</li>\n<li>GAAP costs/expenses rose 38% Y/Y to $419.1M, with sales/marketing accounting for $127.5M and R&amp;D $141.8M. Op. cash flow and free cash flow for the last 12 months are respectively $327.9M and $188.1M. Workday ended FQ1 with $2.1B in cash/investments and $514M in convertible debt.</li>\n<li>\n<a href=\"https://seekingalpha.com/news/3186113-workday-slides-pre-earnings-wedbush-downgrade\" target=\"_blank\">Wedbush downgraded</a> ahead of earnings last Friday, citing soft reseller checks and Workday's performance since February.</li>\n<li>\n<a href=\"https://seekingalpha.com/news/3186444-workday-beats-estimates-guides-consensus-shares-fall\" target=\"_blank\">Workday's results/guidance</a>, earnings release</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3186461\" data-linked=\"Workday slumps in spite of solid results/guidance; unearned revenue up 42%\" data-tweet=\"$WDAY - Workday slumps in spite of solid results/guidance; unearned revenue up 42% https://seekingalpha.com/news/3186461-workday-slumps-in-spite-of-solid-results-guidance-unearned-revenue-up-42?source=tweet\" data-url=\"https://seekingalpha.com/news/3186461-workday-slumps-in-spite-of-solid-results-guidance-unearned-revenue-up-42\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186444\" data-ts=\"1464725099\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDAY\" target=\"_blank\">WDAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186444-workday-beats-estimates-guides-above-consensus-shares-fall\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Workday beats estimates, guides above consensus; shares fall</a></h4><ul>\n<li>Workday (NYSE:<a href=\"https://seekingalpha.com/symbol/WDAY\" title=\"Workday\">WDAY</a>): FQ1 EPS of $0.05 <font color=\"green\">beats by $0.07</font>.</li>\n<li>Revenue of $345.4M (+37.6% Y/Y) <font color=\"green\">beats by $6.72M</font>.</li>\n<li>Expects FQ2 revenue of $371M-$373M (+31%-32% Y/Y), above a $370.9M consensus.</li>\n<li>Shares<font color=\"red\"> -5.1%</font> after hours.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3186444\" data-linked=\"Workday beats estimates, guides above consensus; shares fall\" data-tweet=\"$WDAY - Workday beats estimates, guides above consensus; shares fall https://seekingalpha.com/news/3186444-workday-beats-estimates-guides-above-consensus-shares-fall?source=tweet\" data-url=\"https://seekingalpha.com/news/3186444-workday-beats-estimates-guides-above-consensus-shares-fall\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186438\" data-ts=\"1464724372\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BRCD\" target=\"_blank\">BRCD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186438-ruckus-deal-done-brocadeplus-5-amid-price-target-bumps\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ruckus deal done, Brocade +5% amid price target bumps</a></h4><ul>   <li>With its acquisition of Ruckus Wireless <a href=\"https://seekingalpha.com/news/3186077-brocade-closes-acquisition-ruckus-wireless\" target=\"_blank\">behind it as of Friday</a>, Brocade Communications (NASDAQ:<a href=\"https://seekingalpha.com/symbol/BRCD\" title=\"Brocade Communications Systems, Inc.\">BRCD</a>) is <font color=\"green\">up 5%</font> and Goldman Sachs has raised its price target.</li>    <li>The firm raised to $10, from $9, implying another 11% upside from today's price, though Goldman maintained a Neutral rating.</li>    <li>It sees <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/05/8047634/goldman-sachs-raises-brocade-eps-estimates-on-ruckus-acq\" target=\"_blank\">EPS dilution in the short term</a> as Brocade makes incremental opex investments to sell the new portfolio (fiscal 2016 EPS lowered to $0.92 from $0.98). But it sees accretion for 2017 above the company's target of $0.08-$0.12: Goldman expects $0.14 accretion and raised its 2017 EPS target to $1.13 from $0.99.</li>    <li>It also boosted EPS estimates for fiscal 2018 to $1.23 from $1.02.</li>    <li>After the deal closing, BMO Capital Markets also raised its price target on Brocade, to $9 from $8. That firm maintains a Hold rating on the stock as well.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3186438\" data-linked=\"Ruckus deal done, Brocade +5% amid price target bumps\" data-tweet=\"$BRCD $RKUS - Ruckus deal done, Brocade +5% amid price target bumps https://seekingalpha.com/news/3186438-ruckus-deal-done-brocadeplus-5-amid-price-target-bumps?source=tweet\" data-url=\"https://seekingalpha.com/news/3186438-ruckus-deal-done-brocadeplus-5-amid-price-target-bumps\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186437\" data-ts=\"1464724334\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QLIK\" target=\"_blank\">QLIK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186437-qlik-dives-on-report-of-lower-expected-buyout-price-range\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qlik dives on report of lower-than-expected buyout price range</a></h4><ul>\n<li>\n<a href=\"http://www.reuters.com/article/us-qlik-m-a-thoma-bravo-idUSKCN0YM2HA\" target=\"_blank\">Reuters reports</a> P-E firm Thoma Bravo plans to offer $28-$30/share for Qlik Technologies (<a href=\"https://seekingalpha.com/symbol/QLIK\" title=\"Qlik Technologies Inc.\">QLIK</a> <font color=\"red\">-10%</font>), and that other P-E firms opted not to make binding offers for the business intelligence/analytics software firm \"because of the company's high valuation expectations.\"</li>\n<li>Qlik, which closed on Friday at $31.94, has dived on the report. Shares had rallied since Reuters reported in late March the company is working with Morgan Stanley on a potential sale. <a href=\"https://seekingalpha.com/news/3176692-qlik-draws-preliminary-bids-thoma-bravo-bain-permira\" target=\"_blank\">Bloomberg reported</a> in late April Thoma Bravo and two other P-E firms have made preliminary buyout offers. Activist Elliott Management owns an 8%+ stake.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3186437\" data-linked=\"Qlik dives on report of lower-than-expected buyout price range\" data-tweet=\"$QLIK - Qlik dives on report of lower-than-expected buyout price range https://seekingalpha.com/news/3186437-qlik-dives-on-report-of-lower-expected-buyout-price-range?source=tweet\" data-url=\"https://seekingalpha.com/news/3186437-qlik-dives-on-report-of-lower-expected-buyout-price-range\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186434\" data-ts=\"1464723619\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VMEM\" target=\"_blank\">VMEM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186434-beaten-up-violin-memory-surges-on-strong-volume\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Beaten-up Violin Memory surges on strong volume</a></h4><ul>\n<li>Violin Memory (<a href=\"https://seekingalpha.com/symbol/VMEM\" title=\"Violin Memory, Inc.\">VMEM</a> <font color=\"green\">+24.8%</font>) has risen above $0.50 on volume of 7M shares, far above a 3-month daily average of 1M. No news explaining the move has hit the wires yet.</li>\n<li>The struggling flash storage array vendor is up 41% since posting <a href=\"https://seekingalpha.com/news/3185350-violin-memory-beats-0_01-misses-revenue\" target=\"_blank\">mixed FQ1 results</a> on May 24. However, shares are still down 42% YTD and trade at a small fraction of their $9 2013 IPO price. A strategic review <a href=\"https://seekingalpha.com/news/3166858-violin-memory-plummets-sales-miss-end-review-sales-rebound-promised\" target=\"_blank\">ended in March</a> without a sale.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3186434\" data-linked=\"Beaten-up Violin Memory surges on strong volume\" data-tweet=\"$VMEM - Beaten-up Violin Memory surges on strong volume https://seekingalpha.com/news/3186434-beaten-up-violin-memory-surges-on-strong-volume?source=tweet\" data-url=\"https://seekingalpha.com/news/3186434-beaten-up-violin-memory-surges-on-strong-volume\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186430\" data-ts=\"1464722125\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BA\" target=\"_blank\">BA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186430-boeing-sinks-on-kcminus-46-tanker-delivery-delay\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boeing sinks on KC-46 tanker delivery delay</a></h4><ul>     <li>Boeing (<a href=\"https://seekingalpha.com/symbol/BA\" title=\"The Boeing Company\">BA</a> <font color=\"red\">-2.3%</font>) slumps following <a href=\"https://seekingalpha.com/news/3186139-delivery-new-boeing-aerial-tankers-air-force-will-delayed\" target=\"_blank\">last Friday's announced delay</a> in its program to supply KC-46 aerial refueling tankers to the U.S. Air Force, with the main hangup continuing to be the refueling system and its components, which has contributed significantly to the ~$1.5B in pre-tax charges BA already has taken on the tanker program.</li>     <li>Canaccord analysts say the announcement was a surprise since BA seemed confident about its ability to deliver just three weeks ago at its annual investor day, but considering the technical issues and the still aggressive flight, test and production schedule, the firm says it would not be surprised to see <a href=\"http://blogs.barrons.com/stockstowatchtoday/2016/05/31/boeing-tanking-tanker-tanks-stock/\" target=\"_blank\">further delays</a>.</li>     <li>Canaccord continues to see BA trading in a range as it enjoys significant support from the dividend and the likelihood of continued aggressive share buybacks, \"but the KC-46 announcement highlights the ongoing risk with the tanker program and other significant development programs.\"</li>\n<li>Now read <a href=\"https://seekingalpha.com/article/3978749-boeing-airbus-order-battle-april-2016\" target=\"_blank\"><strong>Boeing and Airbus: The order battle in April 2016</strong></a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3186430\" data-linked=\"Boeing sinks on KC-46 tanker delivery delay\" data-tweet=\"$BA - Boeing sinks on KC-46 tanker delivery delay https://seekingalpha.com/news/3186430-boeing-sinks-on-kcminus-46-tanker-delivery-delay?source=tweet\" data-url=\"https://seekingalpha.com/news/3186430-boeing-sinks-on-kcminus-46-tanker-delivery-delay\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186428\" data-ts=\"1464721795\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PHI\" target=\"_blank\">PHI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186428-philippine-long-distanceplus-12_9-buys-san-miguel-assets\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Philippine Long Distance +12.9% as it buys San Miguel assets</a></h4><ul>   <li>Philippine Long Distance Telephone (NYSE:<a href=\"https://seekingalpha.com/symbol/PHI\" title=\"Philippine Long Distance Telephone Co.\">PHI</a>) is <font color=\"green\">up 12.9%</font> today after news that it would acquire the telecom assets of conglomerate San Miguel Corp., along with Globe Telecom.</li>    <li>The two are spending $1.5B to take over the assets in a 50/50 split. PLDT is putting in about $568M in equity and $185M in assumed debt.</li>    <li>Synergies include higher call quality and faster Internet access across fixed and mobile networks.</li>    <li>Today, San Miguel said the price was <a href=\"http://www.reuters.com/article/us-pldt-globe-telecom-san-miguel-idUSKCN0YM0N9\" target=\"_blank\">enough to cover costs</a> of developing the telecom business. It's selling to the country's main telecom partners because \"no foreign technical partners would like to come in,\" said the company's president, Ramon Ang.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3186428\" data-linked=\"Philippine Long Distance +12.9% as it buys San Miguel assets\" data-tweet=\"$PHI - Philippine Long Distance +12.9% as it buys San Miguel assets https://seekingalpha.com/news/3186428-philippine-long-distanceplus-12_9-buys-san-miguel-assets?source=tweet\" data-url=\"https://seekingalpha.com/news/3186428-philippine-long-distanceplus-12_9-buys-san-miguel-assets\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186426\" data-ts=\"1464721209\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186426-technology-top-5-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/BOSC' title='B.O.S. Better Online Solutions'>BOSC</a> <font color='green'>+101%</font>. <a href='https://seekingalpha.com/symbol/SQI' title='SciQuest, Inc.'>SQI</a> <font color='green'>+33%</font>. <a href='https://seekingalpha.com/symbol/PXLW' title='Pixelworks, Inc.'>PXLW</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/PHI' title='Philippine Long Distance Telephone Co.'>PHI</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/MOBL' title='MobileIron, Inc.'>MOBL</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NLST' title='Netlist, Inc.'>OTC:NLST</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/PDVW' title='pdvWireless, Inc.'>PDVW</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/RENN' title='Renren Inc.'>RENN</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/MXWL' title='Maxwell Technologies, Inc.'>MXWL</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/GSAT' title='Globalstar, Inc.'>GSAT</a> <font color='red'>-5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3186426\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3:00 pm\" data-tweet=\"$BOSC $SQI $PXLW - Technology - Top 5 Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3186426-technology-top-5-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3186426-technology-top-5-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186418\" data-ts=\"1464719014\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WILC\" target=\"_blank\">WILC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186418-g-willi-food-reports-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">G. Willi-Food reports Q1 results</a></h4><ul>\n<li>G. Willi-Food (NASDAQ:<a href=\"https://seekingalpha.com/symbol/WILC\" title=\"G. Willi-Food International, Ltd.\">WILC</a>): Q1 EPS of NIS 0.36</li>\n<li>Revenue of NIS 82.6M (-4.1% Y/Y).</li>\n<li>Shares <font color=\"green\">+5%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3186418\" data-linked=\"G. Willi-Food reports Q1 results\" data-tweet=\"$WILC - G. Willi-Food reports Q1 results https://seekingalpha.com/news/3186418-g-willi-food-reports-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3186418-g-willi-food-reports-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186417\" data-ts=\"1464718871\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DE\" target=\"_blank\">DE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186417-deereplus-2-after-another-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deere +2% after another upgrade</a></h4><ul>     <li>Deere (<a href=\"https://seekingalpha.com/symbol/DE\" title=\"Deere &amp; Company\">DE</a> <font color=\"green\">+2%</font>) is <a href=\"http://blogs.barrons.com/stockstowatchtoday/2016/05/31/deere-el-nino-is-over-must-be-time-for-an-upgrade/?mod=BOL_hp_blog_stw\" target=\"_blank\">upgraded to Buy</a> from Neutral with a $94 price target, raised from $82, at UBS, which says DE's profits are nearing a bottom and higher corn prices should improve sentiment on the shares.</li>     <li>A strong La Niña is on the way based on recent weather patterns, and if the forecast materializes, hot and dry conditions could lower corn yields and increase prices, and sentiment towards DE should improve if corn prices rise, UBS surmises.</li>     <li>The firm also notes that sentiment remains cautious on DE, and short interest is above average for the group.</li>     <li>\n<a href=\"https://seekingalpha.com/news/3185234-deere-rises-upgrade-bmo-capital\" target=\"_blank\">A week ago</a>, BMO Capital upgraded shares to Outperform with a $96 target price.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3186417\" data-linked=\"Deere +2% after another upgrade\" data-tweet=\"$DE - Deere +2% after another upgrade https://seekingalpha.com/news/3186417-deereplus-2-after-another-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3186417-deereplus-2-after-another-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186415\" data-ts=\"1464718410\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186415-immersion-jumps-following-report-2017-iphones-will-support-complex-tactile-vibrations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Immersion jumps following report 2017 iPhones will support &quot;complex tactile vibrations&quot;</a></h4><ul>\n<li>In a report stating Apple (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AAPL\" title=\"Apple Inc.\">AAPL</a>) is moving to a <a href=\"https://seekingalpha.com/news/3186381-nikkei-apple-moving-three-year-upgrade-cycle-iphone\" target=\"_blank\">3-year iPhone upgrade cycle</a>, Japan's <em>Nikkei</em> reports 2017 iPhones <a href=\"http://asia.nikkei.com/Business/Companies/Apple-to-extend-iPhone-s-product-cycle\" target=\"_blank\">will be able</a> to \"create more complex tactile vibrations on the display because of a tiny, but high-performance motor equipped inside.\"</li>\n<li>Haptic tech developer Immersion (<a href=\"https://seekingalpha.com/symbol/IMMR\" title=\"Immersion Corporation\">IMMR</a> <font color=\"green\">+6.8%</font>) appears to be getting a lift from the report. Immersion, which has haptics licensing deals with many Android OEMs, is less than four months removed from <a href=\"https://seekingalpha.com/news/3104396-immersion-sues-apple-and-t-haptics-ip-shares-plus-13-percent\" target=\"_blank\">suing Apple and AT&amp;T</a> for allegedly infringing its IP.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3186415\" data-linked=\"Immersion jumps following report 2017 iPhones will support &quot;complex tactile vibrations&quot;\" data-tweet=\"$AAPL $AAPL $IMMR - Immersion jumps following report 2017 iPhones will support &quot;complex tactile vibrations&quot; https://seekingalpha.com/news/3186415-immersion-jumps-following-report-2017-iphones-will-support-complex-tactile-vibrations?source=tweet\" data-url=\"https://seekingalpha.com/news/3186415-immersion-jumps-following-report-2017-iphones-will-support-complex-tactile-vibrations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186409\" data-ts=\"1464717279\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMRN\" target=\"_blank\">AMRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186409-fda-says-amarins-vascepa-eligible-for-five-year-nce-marketing-exclusivity-shares-up-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA says Amarin&#39;s Vascepa eligible for five-year NCE marketing exclusivity; shares up 7%</a></h4><ul>\n<li>Micro cap Amarin (<a href=\"https://seekingalpha.com/symbol/AMRN\" title=\"Amarin Corporation PLC\">AMRN</a> <font color=\"green\">+7%</font>) is up on double normal volume in response to its announcement that the FDA has determined that Vascepa (icosapent ethyl) capsules are eligible for five-year new chemical entity (NCE) marketing exclusivity under the Hatch-Waxman Amendments to the Federal Food, Drug and Cosmetic Act. The NCE exclusivity will be in effect from the date of FDA approval, July 26, 2012 until July 26, 2017.</li>\n<li>In addition, there is a statutory 30-month stay triggered by patent litigation (the company is automatically notified when a would-be generic competitor files its Abbreviated New Drug Application with the FDA which, in turn, automatically results in patent infringement litigation which triggers the automatic 30-month stay while the patent challenge runs its course) that potentially extends Vascepa's marketing exclusivity to January 26, 2020.</li>\n<li>Vascepa accounted for almost all (99%) of the company's Q1 revenue of $25.5M.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3186409\" data-linked=\"FDA says Amarin&#39;s Vascepa eligible for five-year NCE marketing exclusivity; shares up 7%\" data-tweet=\"$AMRN - FDA says Amarin&#39;s Vascepa eligible for five-year NCE marketing exclusivity; shares up 7% https://seekingalpha.com/news/3186409-fda-says-amarins-vascepa-eligible-for-five-year-nce-marketing-exclusivity-shares-up-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3186409-fda-says-amarins-vascepa-eligible-for-five-year-nce-marketing-exclusivity-shares-up-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186408\" data-ts=\"1464716307\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FRO\" target=\"_blank\">FRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186408-rally-time-for-frontline-and-peers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rally time for Frontline and peers</a></h4><ul> <li>Frontline (<a href='https://seekingalpha.com/symbol/FRO' title='Frontline Ltd.'>FRO</a> <font color='green'>+8.5%</font>)&nbsp;rallies after the company topped revenue expectations with its Q1 report by a wide margin ($227M vs. $187M consensus).</li> <li>The company also pointed to firming tanker rates and said it will stick to its dividend policy.</li> <li>The strong read from Frontline is giving a lift to the broad sector with Ship Finance International (<a href='https://seekingalpha.com/symbol/SFL' title='Ship Finance International Limited'>SFL</a> <font color='green'>+2.9%</font>), DHT Holdings (<a href='https://seekingalpha.com/symbol/DHT' title='DHT Holdings, Inc.'>DHT</a> <font color='green'>+1.5%</font>), Teekay Tankers (<a href='https://seekingalpha.com/symbol/TNK' title='Teekay Tankers Ltd'>TNK</a> <font color='green'>+1.3%</font>), and Gener8 Maritime (<a href='https://seekingalpha.com/symbol/GNRT' title='Gener8 Maritime'>GNRT</a> <font color='green'>+5.5%</font>) all showing gains.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3186408\" data-linked=\"Rally time for Frontline and peers\" data-tweet=\"$FRO $FRO $SFL - Rally time for Frontline and peers https://seekingalpha.com/news/3186408-rally-time-for-frontline-and-peers?source=tweet\" data-url=\"https://seekingalpha.com/news/3186408-rally-time-for-frontline-and-peers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186405\" data-ts=\"1464714373\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186405-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/VRTB-OLD' title='Vestin Realty Mortgage II, Inc.'>VRTB</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/JP' title='Jupai Holdings'>JP</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/MSB' title='Mesabi Trust'>MSB</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/CARV' title='Carver Bancorp, Inc.'>CARV</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SYBT' title='Stock Yards Bancorp, Inc.'>SYBT</a> <font color='red'>-33%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3186405\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$VRTB-OLD $JP $MSB - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3186405-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3186405-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186402\" data-ts=\"1464713423\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186402-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/BOSC' title='B.O.S. Better Online Solutions'>BOSC</a> <font color='green'>+115%</font>. <a href='https://seekingalpha.com/symbol/CPXX' title='Celator Pharmaceuticals, Inc.'>CPXX</a> <font color='green'>+71%</font>. <a href='https://seekingalpha.com/symbol/OPGN' title='OpGen'>OPGN</a> <font color='green'>+50%</font>. <a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs, Inc.'>CLF</a> <font color='green'>+35%</font>. <a href='https://seekingalpha.com/symbol/SQI' title='SciQuest, Inc.'>SQI</a> <font color='green'>+34%</font>. <a href='https://seekingalpha.com/symbol/APHB' title='AmpliPhi Biosciences Corp.'>APHB</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/ELRC' title='Electro Rent Corporation'>ELRC</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/VRTB-OLD' title='Vestin Realty Mortgage II, Inc.'>VRTB</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/ZYNE' title='Zynerba Pharmaceuticals'>ZYNE</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/PXLW' title='Pixelworks, Inc.'>PXLW</a> <font color='green'>+16%</font>.</li><li><b>Losers:</b> STEM <font color='red'>-80%</font>. <a href='https://seekingalpha.com/symbol/SYBT' title='Stock Yards Bancorp, Inc.'>SYBT</a> <font color='red'>-33%</font>. <a href='https://seekingalpha.com/symbol/CCE-OLD' title='Coca-Cola European Partners plc'>CCE-OLD</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/KOOL' title='Cesca Therapeutics Inc'>KOOL</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/OSIR' title='Osiris Therapeutics, Inc.'>OSIR</a> <font color='red'>-10%</font>. PSDV <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/AMSC' title='American Superconductor Corporation'>AMSC</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/LINC' title='Lincoln Educational Services Corporation'>LINC</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/LFVN' title='LifeVantage Corporation'>LFVN</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/FSI' title='Flexible Solutions International, Inc'>FSI</a> <font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3186402\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$BOSC $CPXX $OPGN - Midday Gainers / Losers https://seekingalpha.com/news/3186402-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3186402-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186400\" data-ts=\"1464712874\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TK\" target=\"_blank\">TK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186400-teekay-price-target-hiked-to-8-morgan-stanley\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teekay price target hiked to $8 at Morgan Stanley</a></h4><ul>     <li>Teekay (<a href=\"https://seekingalpha.com/symbol/TK\" title=\"Teekay Corporation\">TK</a> <font color=\"green\">+4.2%</font>) \u201ccontinues to enjoy strong support from its lenders and its major shareholder that are willing to provide additional capital to deal with the funding gap\" from its $4.6B capex, Morgan Stanley says as it maintains its Equal Weight rating on the stock while <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/05/8047848/morgan-stanley-raises-teekays-price-target-to-8-says-gai\" target=\"_blank\">raising its price target to $8</a> from $7.</li>     <li>Stanley says Teekay Offshore Partners (<a href=\"https://seekingalpha.com/symbol/TOO\" title=\"Teekay Offshore Partners L.P.\">TOO</a> <font color=\"green\">+4%</font>) is close to completing its capitalization plan, which is expected to improve liquidity while deferring any funding gap to after 2017, while the funding gap for Teekay LNG Partners (<a href=\"https://seekingalpha.com/symbol/TGP\" title=\"Teekay LNG Partners L.P.\">TGP</a> <font color=\"green\">+1.2%</font>) appears to be narrowing, with management expecting high newbuild financing.</li>     <li>However, the firm also notes that TOO continues to have the highest exposure in the group to high dilution risk, given its expiring offshore contracts, large debt maturities and aging assets.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3186400\" data-linked=\"Teekay price target hiked to $8 at Morgan Stanley\" data-tweet=\"$TK $TK $TOO - Teekay price target hiked to $8 at Morgan Stanley https://seekingalpha.com/news/3186400-teekay-price-target-hiked-to-8-morgan-stanley?source=tweet\" data-url=\"https://seekingalpha.com/news/3186400-teekay-price-target-hiked-to-8-morgan-stanley\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186397\" data-ts=\"1464712047\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186397-micron-gains-on-baird-upgrade-3d-nand-ssds-launched\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Micron gains on Baird upgrade; 3D NAND SSDs launched</a></h4><ul>\n<li>Nine months after <a href=\"https://seekingalpha.com/news/2738696-micron-another-4_1-percent-following-baird-downgrade\" target=\"_blank\">downgrading</a> Micron (<a href=\"https://seekingalpha.com/symbol/MU\" title=\"Micron Technology Inc.\">MU</a> <font color=\"green\">+2.8%</font>) to Neutral on DRAM pricing worries (shares were at $15.90 then), Baird's Tristan Gerra has <a href=\"http://blogs.barrons.com/techtraderdaily/2016/05/31/micron-rising-baird-ups-to-buy-on-view-samsung-will-cool-dram-push-2/\" target=\"_blank\">upgraded to Outperform</a>, and hiked his target by $3 to $21.</li>\n<li>He thinks DRAM and NAND conditions are improving, believes Samsung might \"shift a meaningful amount of capacity from DRAM to NAND\" in 2H16, and expects NAND demand benefit from the iPhone 7 launch (<a href=\"http://www.macrumors.com/2016/01/02/iphone-7-plus-256gb-storage-3100-mah-battery/\" target=\"_blank\">expected to include</a> the arrival of a 256GB model) and rising <a href=\"http://www.dramexchange.com/WeeklyResearch/Post/2/4374.html\" target=\"_blank\">PC SSD adoption</a>.</li>\n<li>Gerra: \"We expect DRAM pricing to decline by about 10% a quarter for the rest of the year, while Micron has an opportunity for a 10-15% improvement in its DRAM cost structure in 2H16 versus 1H16 as a result of an improving 20nm mix.\" His FY16 (ends Aug. '16) and FY17 estimates have been upped.</li>\n<li>Separately, Micron has announced two SSDs relying on 3D NAND flash: The 1100, which has a traditional SATA interface, and the 2100, which features a next-gen PCIe NVMe interface. The company promises \" extreme read performance that is up to 1900X faster for the 2100 SSD and 900X faster for the 1100 SSD, configured running client standard implementation, when compared to [hard drives].\"</li>\n<li>The 1100 enters production in July, and the 2100 will do so later this summer. Micron and NAND partner Intel <a href=\"https://seekingalpha.com/news/2394936-intel-micron-launch-3d-nand-line-promise-cost-capacity-edge-updated\" target=\"_blank\">first announced</a> their 3D NAND line in March 2015, while promising density/cost advantages over rivals. Samsung and SanDisk/Toshiba have also been investing heavily in growing 3D NAND production.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3186397\" data-linked=\"Micron gains on Baird upgrade; 3D NAND SSDs launched\" data-tweet=\"$MU - Micron gains on Baird upgrade; 3D NAND SSDs launched https://seekingalpha.com/news/3186397-micron-gains-on-baird-upgrade-3d-nand-ssds-launched?source=tweet\" data-url=\"https://seekingalpha.com/news/3186397-micron-gains-on-baird-upgrade-3d-nand-ssds-launched\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186396\" data-ts=\"1464711771\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLOFY\" target=\"_blank\">GLOFY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186396-report-vivendi-votes-to-control-gameloft\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Report: Vivendi has votes to control Gameloft</a></h4><ul>   <li>Vivendi (<a href='https://seekingalpha.com/symbol/VIVHY' title='Vivendi SA ADR'>OTCPK:VIVHY</a> <font color='red'>-0.5%</font>) now has the <a href=\"http://www.telecompaper.com/news/vivendi-has-enough-votes-to-buy-over-half-of-gameloft--1146115\" target=\"_blank\">votes to take over Gameloft</a> (<a href='https://seekingalpha.com/symbol/GLOFY' title='Gameloft SA ADR'>OTCPK:GLOFY</a>) after its unwelcome pursuit of the game maker, according to <i>Les Echos.</i></li>    <li>It was the acquisition of <a href=\"https://seekingalpha.com/news/3184803-vivendi-get-ambers-gameloft-stake-control-44-percent-shares\" target=\"_blank\">Amber Capital's roughly 30% stake</a> earlier this month that made the difference, the paper says. Detailed figures aren't certain but it's expected that Vivendi has a 50%-plus voting stake now.</li>    <li>Vivendi had accumulated around 15% of Gameloft and Ubisoft (<a href='https://seekingalpha.com/symbol/UBSFY' title='UbiSoft Entertainment Inc. ADR'>OTCPK:UBSFY</a> <font color='green'>+2.2%</font>), each controlled by the Guillemot family, through gradual purchases. It's unclear how much of Gameloft the Guillemots still control.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3186396\" data-linked=\"Report: Vivendi has votes to control Gameloft\" data-tweet=\"$GLOFY $GLOFY $VIVHY - Report: Vivendi has votes to control Gameloft https://seekingalpha.com/news/3186396-report-vivendi-votes-to-control-gameloft?source=tweet\" data-url=\"https://seekingalpha.com/news/3186396-report-vivendi-votes-to-control-gameloft\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186394\" data-ts=\"1464711561\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MON\" target=\"_blank\">MON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186394-report-bayer-to-sweeten-monsanto-offer-to-135-share\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Report: Bayer to sweeten Monsanto offer to $135/share</a></h4><ul>     <li>Monsanto (<a href=\"https://seekingalpha.com/symbol/MON\" title=\"Monsanto Company\">MON</a> <font color=\"green\">+2.2%</font>) pops to highs of the day amid chatter that Bayer (<a href=\"https://seekingalpha.com/symbol/BAYRY\" title=\"Bayer A.G. ADR\">OTCPK:BAYRY</a> <font color=\"green\">+0.3%</font>) will move to increase its $122/share takeover bid as early as this week.</li>     <li>MON shares, already higher following a <a href=\"http://www.thetimes.co.uk/article/bayer-ready-to-beef-up-offer-for-monsanto-5fb8d82mw\" target=\"_blank\"><em>Sunday Times </em>report</a> suggesting the company could be receiving an improved takeover bid, extend gains after Street Insider reports Bayer is <a href=\"http://www.streetinsider.com/Hot+M+and+A/Bayer+to+Offer+%24135Share+in+Sweetened+Bid+for+Monsanto+%28MON%29+-+Source/11689826.html\" target=\"_blank\">preparing to offer $135/share</a>, citing \"a source claiming to have knowledge of the situation.\"</li>\n<li>Now read <a href=\"https://seekingalpha.com/news/3186164-bloomberg-bayer-meeting-banks-monsanto-funding\" target=\"_blank\"><strong>Bloomberg: Bayer meeting with banks on Monsanto funding</strong></a> (May 27)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3186394\" data-linked=\"Report: Bayer to sweeten Monsanto offer to $135/share\" data-tweet=\"$MON $MON $BAYRY - Report: Bayer to sweeten Monsanto offer to $135/share https://seekingalpha.com/news/3186394-report-bayer-to-sweeten-monsanto-offer-to-135-share?source=tweet\" data-url=\"https://seekingalpha.com/news/3186394-report-bayer-to-sweeten-monsanto-offer-to-135-share\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186387\" data-ts=\"1464710472\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186387-consumer-goods-top-gainers-losers-of-12-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer Goods - Top Gainers / Losers as of 12:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/TTM' title='Tata Motors Limited'>TTM</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/NAV' title='Navistar International Corporation'>NAV</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CCE-OLD' title='Coca-Cola European Partners plc'>CCE-OLD</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/LFVN' title='LifeVantage Corporation'>LFVN</a> <font color='red'>-8%</font>. AOI <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3186387\" data-linked=\"Consumer Goods - Top Gainers / Losers as of 12:00 am\" data-tweet=\"$TTM $NAV $CCEP - Consumer Goods - Top Gainers / Losers as of 12:00 am https://seekingalpha.com/news/3186387-consumer-goods-top-gainers-losers-of-12-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3186387-consumer-goods-top-gainers-losers-of-12-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186385\" data-ts=\"1464710007\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LXRX\" target=\"_blank\">LXRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186385-fda-accepts-lexicon-pharmas-telotristat-etiprate-nda-for-carcinoid-syndrome-action-date\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA accepts Lexicon Pharma&#39;s telotristat etiprate NDA for carcinoid syndrome; action date November 30; shares up 3%</a></h4><ul>\n<li>The FDA <a href=\"http://www.prnewswire.com/news-releases/lexicon-announces-fda-priority-review-of-new-drug-application-for-telotristat-etiprate-for-the-treatment-of-carcinoid-syndrome-300276716.html\" target=\"_blank\">accepts for review</a> Lexicon Pharmaceuticals' (<a href=\"https://seekingalpha.com/symbol/LXRX\" title=\"Lexicon Pharmaceuticals, Inc.\">LXRX</a> <font color=\"green\">+3.1%</font>) New Drug Application (NDA) seeking approval of telotristat etiprate for he treatment of <a href=\"http://www.mayoclinic.org/diseases-conditions/carcinoid-syndrome/basics/definition/con-20027127\" target=\"_blank\">carcinoid syndrome</a>, a rare condition that affects some cancer patients with metastatic neuroendocrine tumors (mNETs) that have spread to the liver and other organs from the GI tract. It is characterized by frequent and debilitating diarrhea, facial flushing, abdominal pain, fatigue and, eventually, heart valve damage.</li>\n<li>\n<a href=\"http://www.lexpharma.com/pipeline/telotristat-etiprate.html\" target=\"_blank\">Telotristat etiprate</a> inhibits tryptophan hydroxylase, an enzyme that triggers excess serotonin production within mNET cells that leads to carcinoid syndrome.</li>\n<li>The agency's action date (PDUFA) is November 30 as allowed under Priority Review status.</li>\n<li>Shares are up <font color=\"green\">3%</font> on average volume.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3186385\" data-linked=\"FDA accepts Lexicon Pharma&#39;s telotristat etiprate NDA for carcinoid syndrome; action date November 30; shares up 3%\" data-tweet=\"$LXRX - FDA accepts Lexicon Pharma&#39;s telotristat etiprate NDA for carcinoid syndrome; action date November 30; shares up 3% https://seekingalpha.com/news/3186385-fda-accepts-lexicon-pharmas-telotristat-etiprate-nda-for-carcinoid-syndrome-action-date?source=tweet\" data-url=\"https://seekingalpha.com/news/3186385-fda-accepts-lexicon-pharmas-telotristat-etiprate-nda-for-carcinoid-syndrome-action-date\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186378\" data-ts=\"1464708616\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MOBL\" target=\"_blank\">MOBL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186378-mobileiron-soars-after-unveiling-cloud-based-emm-solution-deutsche-telekom\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MobileIron soars after unveiling cloud-based EMM solution with Deutsche Telekom</a></h4><ul>\n<li>MobileIron (<a href=\"https://seekingalpha.com/symbol/MOBL\" title=\"MobileIron, Inc.\">MOBL</a> <font color=\"green\">+12.5%</font>) and German telecom giant Deutsche Telekom have unveiled Hosted MDM Basic, a cloud-based enterprise mobility management (EMM) offering based on MobileIron's software and hosted in DT's German data centers.</li>\n<li>The companies declare the solution \"adheres to Germany's data protection regulations and satisfies the privacy requirements of German enterprise customers and public sector institutions.\" European carriers Slovak Telekom, Hrvatski Telekom, and Cosmote will also be reselling the service.</li>\n<li>Microsoft <a href=\"http://windowsitpro.com/cloud/microsoft-opens-azure-cloud-germany-even-it-cant-access-easily\" target=\"_blank\">has already partnered</a> with DT to offer cloud services that address local privacy/data-retention concerns. MobileIron is up sharply after having closed on Friday just $0.18 above a post-IPO low of $2.78 (set on May 23).</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3186378\" data-linked=\"MobileIron soars after unveiling cloud-based EMM solution with Deutsche Telekom\" data-tweet=\"$MOBL - MobileIron soars after unveiling cloud-based EMM solution with Deutsche Telekom https://seekingalpha.com/news/3186378-mobileiron-soars-after-unveiling-cloud-based-emm-solution-deutsche-telekom?source=tweet\" data-url=\"https://seekingalpha.com/news/3186378-mobileiron-soars-after-unveiling-cloud-based-emm-solution-deutsche-telekom\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186377\" data-ts=\"1464708272\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EQNR\" target=\"_blank\">EQNR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186377-statoil-downgraded-rbc-which-sees-cash-generation-challenges\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Statoil downgraded at RBC, which sees cash generation challenges</a></h4><ul>     <li>Statoil (STO <font color=\"red\">-2%</font>) is <a href=\"http://business.financialpost.com/investing/trading-desk/statoil-asa-downgraded-to-underperform\" target=\"_blank\">downgraded</a> to Underperform from Sector Perform at RBC, which believes the company's cash generation will be weaker than its peers and that its significant exposure to European natural gas will prove to be a further headwind.</li>\n<li>RBC says STO continues to drive down its costs in the upstream while also consistently surprising the market with multiple capex reductions, but that the stock's upside potential appears limited given strong YTD gains.</li>          <li>The firm notes that STO's financial positioning requires crude oil prices near $70/bbl for its current plan to work out in the near term, which remains near the top of its peer group.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3186377\" data-linked=\"Statoil downgraded at RBC, which sees cash generation challenges\" data-tweet=\"$EQNR - Statoil downgraded at RBC, which sees cash generation challenges https://seekingalpha.com/news/3186377-statoil-downgraded-rbc-which-sees-cash-generation-challenges?source=tweet\" data-url=\"https://seekingalpha.com/news/3186377-statoil-downgraded-rbc-which-sees-cash-generation-challenges\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186373\" data-ts=\"1464707274\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDP\" target=\"_blank\">MDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186373-time-inc-says-myspace-suffered-data-breach\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Time Inc. says MySpace suffered data breach</a></h4><ul>   <li>Time Inc. (<a href=\"https://seekingalpha.com/symbol/TIME\" target=\"_blank\">TIME</a> <font color=\"green\">+2%</font>) says that MySpace -- the former social-networking power that it acquired in February -- suffered a data breach and that stolen login data appeared in an online forum just before Memorial Day weekend.</li>    <li>The company says exposed data is limited to the time before a 2013 relaunch that strengthened security, and that the breach doesn't affect any of Time Inc.'s other systems or media properties, and no financial data of any kind.</li>    <li>It says it's invalidated the passwords of known affected users and is working with law enforcement.</li>    <li>Time got MySpace through an <a href=\"https://seekingalpha.com/news/3102446-time-inc-9_4-percent-profits-miss-company-buys-myspace\" target=\"_blank\">acquisition of the assets of Viant</a> in February.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3186373\" data-linked=\"Time Inc. says MySpace suffered data breach\" data-tweet=\"$MDP - Time Inc. says MySpace suffered data breach https://seekingalpha.com/news/3186373-time-inc-says-myspace-suffered-data-breach?source=tweet\" data-url=\"https://seekingalpha.com/news/3186373-time-inc-says-myspace-suffered-data-breach\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186371\" data-ts=\"1464706874\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186371-latest-brexit-poll-sends-pound-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Latest Brexit poll sends pound lower</a></h4><ul><li>In somewhat of a shock given recent polling showing the \"Remain\" camp leading by a solid amount, <a href=\"http://www.theguardian.com/politics/2016/may/31/uk-voters-leaning-towards-brexit-guardian-poll-reveals\" target=\"_blank\">two new polls</a> show those favoring a Brexit having the upper hand by 52% to 48%.</li><li>The news has sent the pound (NYSEARCA:<a href='https://seekingalpha.com/symbol/FXB' title='CurrencyShares British Pound Sterling Trust ETF'>FXB</a>)<font color='red'> lower by 0.6%</font>&nbsp;vs. the dollar and&nbsp;<font color='red'>0.5%</font>&nbsp;vs. the euro (NYSEARCA:<a href='https://seekingalpha.com/symbol/FXE' title='CurrencyShares Euro Trust ETF'>FXE</a>). The FTSE 100 is<font color='red'> lower by 0.2%</font>, but it's the best performer in Europe today.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/EWU' title='iShares MSCI United Kingdom ETF'>EWU</a>, <a href='https://seekingalpha.com/symbol/EWUS' title='iShares MSCI United Kingdom Small Cap Index ETF'>EWUS</a>, <a href='https://seekingalpha.com/symbol/FKU' title='First Trust United Kingdom AlphaDex ETF'>FKU</a>, <a href='https://seekingalpha.com/symbol/DXPS' title='WisdomTree United Kingdom Hedged Equity ETF'>DXPS</a>, <a href='https://seekingalpha.com/symbol/DBUK' title='Deutsche X-trackers MSCI United Kingdom Hedged Equity ETF'>DBUK</a>, <a href='https://seekingalpha.com/symbol/QGBR' title='SPDR MSCI United Kingdom Quality Mix ETF'>QGBR</a>, <a href='https://seekingalpha.com/symbol/HEWU' title='iShares Currency Hedged MSCI United Kingdom ETF'>HEWU</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3186371\" data-linked=\"Latest Brexit poll sends pound lower\" data-tweet=\"$FXB $FXE $EWU - Latest Brexit poll sends pound lower https://seekingalpha.com/news/3186371-latest-brexit-poll-sends-pound-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3186371-latest-brexit-poll-sends-pound-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186367\" data-ts=\"1464706813\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186367-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CPXX' title='Celator Pharmaceuticals, Inc.'>CPXX</a> <font color='green'>+71%</font>. <a href='https://seekingalpha.com/symbol/OPGN' title='OpGen'>OPGN</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/NNVC' title='NanoViricides, Inc.'>NNVC</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/APHB' title='AmpliPhi Biosciences Corp.'>APHB</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/CYTR' title='CytRx Corporation'>CYTR</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> STEM <font color='red'>-82%</font>. <a href='https://seekingalpha.com/symbol/OSIR' title='Osiris Therapeutics, Inc.'>OSIR</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/KOOL' title='Cesca Therapeutics Inc'>KOOL</a> <font color='red'>-11%</font>. PSDV <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/AKER' title='Akers Biosciences Inc.'>AKER</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3186367\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$CPXX $OPGN $NNVC - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3186367-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3186367-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186366\" data-ts=\"1464706802\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBOT\" target=\"_blank\">MBOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186366-stemcells-nixes-mid-stage-study-in-spinal-cord-injury-shares-plummet-82\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">StemCells nixes mid-stage study in spinal cord injury; shares plummet 82%</a></h4><ul>\n<li>Thinly traded nano cap StemCells (STEM <font color=\"red\">-81.9%</font>) craters on almost a 20x surge in volume in response to its <a href=\"https://www.sec.gov/Archives/edgar/data/883975/000129993316002563/exhibit1.htm\" target=\"_blank\">announcement</a> that it has terminated its Phase 2 Pathway Study, assessing its HuCNS-SC human neural stem cells in spinal cord injury, due to lack of demonstrated effect, specifically a declining trend in the magnitude of treatment effect in both strength and function at month 12. An analysis by the Data Monitoring Committee showed the study was unlikely to achieve its primary efficacy endpoint.</li>\n<li>Bullish expectations stoked a brief rally several weeks ago after the company reported positive interim results from six patients.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3182331-bullish-investors-stoke-buying-stemcells-ahead-pathway-study-data-release-shares-22-percent\" target=\"_blank\">Bullish investors stoke buying in StemCells ahead of Pathway study data release; shares up 22%</a> (May 11)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3186366\" data-linked=\"StemCells nixes mid-stage study in spinal cord injury; shares plummet 82%\" data-tweet=\"$MBOT - StemCells nixes mid-stage study in spinal cord injury; shares plummet 82% https://seekingalpha.com/news/3186366-stemcells-nixes-mid-stage-study-in-spinal-cord-injury-shares-plummet-82?source=tweet\" data-url=\"https://seekingalpha.com/news/3186366-stemcells-nixes-mid-stage-study-in-spinal-cord-injury-shares-plummet-82\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186368\" data-ts=\"1464706498\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTM\" target=\"_blank\">TTM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186368-tata-motors-rallies-after-posting-strong-quarter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tata Motors rallies after posting strong quarter</a></h4><ul> <li>Tata Motors (<a href=\"https://seekingalpha.com/symbol/TTM\" title=\"Tata Motors Limited\">TTM</a> <font color=\"green\">+13.4%</font>) soars after Q4 earnings shine.</li> <li>The automobile company benefited from <a href=\"http://blogs.barrons.com/asiastocks/2016/05/30/tata-motors-march-quarter-strong-beat-jaguar-soared/\" target=\"_blank\">strong pricing</a> in China from the premium segment on top of volume gains in Europe.</li> <li>Net income tripled to 51.8B rupees ($771M) during the quarter to smash the consensus estimate of 35.3B billion rupees.</li>\n<li>On Wall Street, Morgan Stanley points at JLR's profit margin which came in at 16.2% vs. the 15.3% expected by the investment firm. Bernstein Research notes the Jaguar plan is working like clockwork so far.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3186203-tata-motors-reports-q4-results\" target=\"_blank\">Tata Motors reports Q4 results</a> (May 30)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3186368\" data-linked=\"Tata Motors rallies after posting strong quarter\" data-tweet=\"$TTM - Tata Motors rallies after posting strong quarter https://seekingalpha.com/news/3186368-tata-motors-rallies-after-posting-strong-quarter?source=tweet\" data-url=\"https://seekingalpha.com/news/3186368-tata-motors-rallies-after-posting-strong-quarter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186364\" data-ts=\"1464706137\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/S\" target=\"_blank\">S</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186364-supreme-court-rejects-sprint-bid-to-set-aside-new-york-tax-suit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Supreme Court rejects Sprint bid to set aside New York tax suit</a></h4><ul>   <li>The Supreme Court has <a href=\"http://www.reuters.com/article/usa-courts-sprint-corp-idUSL1N18S0LN\" target=\"_blank\">rejected an appeal</a> by Sprint (<a href=\"https://seekingalpha.com/symbol/S\" title=\"Sprint Corporation\">S</a> <font color=\"green\">+4.5%</font>) of an attempt by New York state to collect $300M in a tax case.</li>    <li>The state says Sprint deliberately didn't bill customers for taxes on wireless service over seven years, amounting to more than $100M, and it's seeking triple that amount in total damages and penalties. Sprint had argued that federal telecom law applied rather than a New York law imposing sales tax on interstate mobile service.</li>    <li>The decision leaves in place an October ruling in favor of New York.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3186364\" data-linked=\"Supreme Court rejects Sprint bid to set aside New York tax suit\" data-tweet=\"$S - Supreme Court rejects Sprint bid to set aside New York tax suit https://seekingalpha.com/news/3186364-supreme-court-rejects-sprint-bid-to-set-aside-new-york-tax-suit?source=tweet\" data-url=\"https://seekingalpha.com/news/3186364-supreme-court-rejects-sprint-bid-to-set-aside-new-york-tax-suit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186360\" data-ts=\"1464705860\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OSIR\" target=\"_blank\">OSIR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186360-osiris-subject-of-criminal-investigation-shares-off-15\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Osiris subject of criminal investigation; shares off 15%</a></h4><ul><li>Thinly traded micro cap Osiris Therapeutics (<a href='https://seekingalpha.com/symbol/OSIR' title='Osiris Therapeutics, Inc.'>OSIR</a> <font color='red'>-14.8%</font>) is down on higher-than-normal volume in response to a <a href=\"https://www.sec.gov/Archives/edgar/data/1360886/000110465916124092/a16-12401_18k.htm\" target=\"_blank\">regulatory filing</a> in which the company discloses that it is the target of a criminal investigation by the U.S. Attorney's Office for the Southern District of New York concerning matters currently being investigated by the SEC.</li></ul><div class=\"tiny-share-widget\" data-id=\"3186360\" data-linked=\"Osiris subject of criminal investigation; shares off 15%\" data-tweet=\"$OSIR - Osiris subject of criminal investigation; shares off 15% https://seekingalpha.com/news/3186360-osiris-subject-of-criminal-investigation-shares-off-15?source=tweet\" data-url=\"https://seekingalpha.com/news/3186360-osiris-subject-of-criminal-investigation-shares-off-15\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186356\" data-ts=\"1464704561\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMSC\" target=\"_blank\">AMSC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186356-american-superconductor-sells-off-due-to-soft-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Superconductor sells off due to soft guidance</a></h4><ul>\n<li>Though American Superconductor (<a href=\"https://seekingalpha.com/symbol/AMSC\" title=\"American Superconductor Corporation\">AMSC</a> <font color=\"red\">-6.9%</font>) beat FQ4 estimates, the company is guiding for FQ1 revenue of $12M-$14M (below a 2-analyst $20.7M consensus, and down from $23.7M a year earlier) and EPS above -$0.94 (compares with a -$0.51 consensus, and year-ago EPS of -$0.72).</li>\n<li>The company blames \"historical seasonality\" at Indian wind turbine component client <a href=\"https://seekingalpha.com/news/2990646-amsc-28_7-percent-announcing-210m-worth-deals-inox-wind\" target=\"_blank\">Inox Wind</a>, while adding this seasonality has been \"compounded by what has been described by Inox as a near-term working capital constraint.\"</li>\n<li>Wind division revenue fell $1.2M Y/Y in FQ4 to $19.9M. Grid (smart grid component) division revenue rose by $3.5M to $7.6M. Gross margin was 50.5%, R&amp;D spend rose by $500K to $3.4M, and SG&amp;A spend rose by $1.8M to $7.5M. AMSC ended FQ4 with $40.7M in cash, up $3M Q/Q.</li>\n<li>\n<a href=\"https://seekingalpha.com/news/3186308-american-superconductor-beats-0_32-beats-revenue\" target=\"_blank\">AMSC's FQ4 results</a>, earnings release</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3186356\" data-linked=\"American Superconductor sells off due to soft guidance\" data-tweet=\"$AMSC - American Superconductor sells off due to soft guidance https://seekingalpha.com/news/3186356-american-superconductor-sells-off-due-to-soft-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3186356-american-superconductor-sells-off-due-to-soft-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186355\" data-ts=\"1464704237\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLF\" target=\"_blank\">CLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186355-cliffs-naturalplus-38-following-long-term-deal-arcelormittal-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cliffs Natural +38% following long-term deal with ArcelorMittal, upgrade</a></h4><ul>     <li>Cliffs Natural Resources (<a href=\"https://seekingalpha.com/symbol/CLF\" title=\"Cleveland-Cliffs, Inc.\">CLF</a> <font color=\"green\">+38.4%</font>) rockets higher following an <a href=\"https://seekingalpha.com/news/3186329-cliffs-natural-resources-plus-30-percent-j-p-morgan-upgrades\" target=\"_blank\">upgrade from J.P. Morgan</a> and signing a commercial agreement with ArcelorMittal.</li>     <li>JPM had upgraded shares to Overweight from Neutral with a $7 price target, saying that rising steel sheet prices should aid earnings for the remaining quarters of 2016 and that steel pellet contracts with MT likely will be renewed favorably; as if on cue, CLF then announced a 10-year pellet supply agreement with MT.</li>     <li>CLF says the new supply deal replaces two existing contracts that expire in December 2016 and 2017, raises the minimum tonnage of pellets to a higher level than previous agreements, and preserves the company's position as sole iron ore pellet supplier of MT's Indiana Harbor West and Cleveland Works steelmaking facilities, while maintaining the current level of pellet supply to  MT's Indiana Harbor East facility.</li>     <li>\"The new agreement also removes any remaining uncertainty about Cliffs,\" Chairman and CEO Lourenco Goncalves says.</li>\n<li>Now read <a href=\"https://seekingalpha.com/news/3186169-cliffs-natural-still-viewed-negatively-axiom-coming-deluge-iron-ore\" target=\"_blank\"><strong>Cliffs Natural still viewed negatively at Axiom on \"coming deluge of iron ore\"</strong></a> (from May 27)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3186355\" data-linked=\"Cliffs Natural +38% following long-term deal with ArcelorMittal, upgrade\" data-tweet=\"$CLF - Cliffs Natural +38% following long-term deal with ArcelorMittal, upgrade https://seekingalpha.com/news/3186355-cliffs-naturalplus-38-following-long-term-deal-arcelormittal-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3186355-cliffs-naturalplus-38-following-long-term-deal-arcelormittal-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>45&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186353\" data-ts=\"1464703931\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGN\" target=\"_blank\">AGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186353-allergan-up-on-news-of-icahn-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Allergan up on news of Icahn stake</a></h4><ul><li>Although up a bit more premarket, Allergan (<a href=\"https://seekingalpha.com/symbol/AGN\" title=\"Allergan plc\">AGN</a> <font color=\"green\">+1.2%</font>) is still up modestly on the news that investor Carl Icahn has <a href=\"http://www.marketwatch.com/story/allergans-stock-surges-after-carl-icahn-discloses-large-stake-2016-05-31\" target=\"_blank\">acquired a large stake</a> in the BOTOX maker.</li></ul><div class=\"tiny-share-widget\" data-id=\"3186353\" data-linked=\"Allergan up on news of Icahn stake\" data-tweet=\"$AGN - Allergan up on news of Icahn stake https://seekingalpha.com/news/3186353-allergan-up-on-news-of-icahn-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/3186353-allergan-up-on-news-of-icahn-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186349\" data-ts=\"1464703345\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MKTO\" target=\"_blank\">MKTO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186349-vista-equity-buying-marketo-for-1_79b-35_25-share\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vista Equity buying Marketo for $1.79B ($35.25/share)</a></h4><ul>\n<li>A few days after <a href=\"https://seekingalpha.com/news/3186128-marketo-jumps-report-p-e-buyout-deal-close\" target=\"_blank\">dealReporter stated</a>   P-E firm Vista Equity is close to a deal to buy Marketo   (<a href=\"https://seekingalpha.com/symbol/MKTO\" title=\"Marketo\">MKTO</a> <font color=\"green\">+8.9%</font>), the cloud marketing automation software firm   announces Vista is buying the company   for $35.25/share in cash. The price represents a 9% premium to  Friday's  close, and a 64% premium to where Marketo closed on May 9,  before the  first sale report <a href=\"https://seekingalpha.com/news/3181842-marketo-jumps-15-percent-chatter-exploring-possible-sale\" target=\"_blank\">arrived</a>.</li>\n<li>The deal, the latest in a flurry of P-E purchases of enterprise tech firms, is expected to close in Q3.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3186349\" data-linked=\"Vista Equity buying Marketo for $1.79B ($35.25/share)\" data-tweet=\"$MKTO - Vista Equity buying Marketo for $1.79B ($35.25/share) https://seekingalpha.com/news/3186349-vista-equity-buying-marketo-for-1_79b-35_25-share?source=tweet\" data-url=\"https://seekingalpha.com/news/3186349-vista-equity-buying-marketo-for-1_79b-35_25-share\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186344\" data-ts=\"1464703136\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PXLW\" target=\"_blank\">PXLW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186344-pixelworks-display-processor-making-smartphone-debut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pixelworks display processor making smartphone debut</a></h4><ul>    <li>Pixelworks (<a href=\"https://seekingalpha.com/symbol/PXLW\" title=\"Pixelworks, Inc.\">PXLW</a> <font color=\"green\">+6.4%</font>) says that its video enhancement chip is making its smartphone debut, in a new device from Asus.</li>    <li>The Iris display processor will appear in Asus' ZenFone 3 Ultra, a 6.8-inch phone boasting big-screen HD video along with a Qualcomm 8976 applications processor.</li>    <li>The device has a 6.8-inch LCD panel with full HD resolution and will use Pixelworks' True Clarity video enhancement to reduce motion blur on applications such as watching live sports.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3186344\" data-linked=\"Pixelworks display processor making smartphone debut\" data-tweet=\"$PXLW - Pixelworks display processor making smartphone debut https://seekingalpha.com/news/3186344-pixelworks-display-processor-making-smartphone-debut?source=tweet\" data-url=\"https://seekingalpha.com/news/3186344-pixelworks-display-processor-making-smartphone-debut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186343\" data-ts=\"1464703039\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELRC\" target=\"_blank\">ELRC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186343-buyout-announced-for-electo-rent-corporation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Buyout announced for Electo Rent Corporation</a></h4><ul> <li>Shares of Electro Rent Corporation (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ELRC\" title=\"Electro Rent Corporation\">ELRC</a>) soar after the company announces it will be acquired by Platinum Equity for $13.12 per share in a deal valued at $323.4M.</li> <li>Chairman Daniel Greenberg and his family say they will support the merger with their 29% stake.</li> <li>Electro Rent will skip its dividend due to be paid out in July due to the buyout development.</li> <li>ELRC <font color=\"green\">+22.83%</font> to $12.96.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3186343\" data-linked=\"Buyout announced for Electo Rent Corporation\" data-tweet=\"$ELRC - Buyout announced for Electo Rent Corporation https://seekingalpha.com/news/3186343-buyout-announced-for-electo-rent-corporation?source=tweet\" data-url=\"https://seekingalpha.com/news/3186343-buyout-announced-for-electo-rent-corporation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186342\" data-ts=\"1464702818\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRO\" target=\"_blank\">MRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186342-marathon-oil-upped-to-outperform-piper-jaffray\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marathon Oil upped to Outperform at Piper Jaffray</a></h4><ul>     <li>Marathon Oil (<a href=\"https://seekingalpha.com/symbol/MRO\" title=\"Marathon Oil Corporation\">MRO</a> <font color=\"green\">+4.6%</font>) is <a href=\"http://www.streetinsider.com/Analyst+Comments/Simmons+Upgrades+Marathon+Oil+%28MRO%29+to+Overweight%3B+25%25+Upside/11688065.html\" target=\"_blank\">upgraded</a> to Overweight from Neutral with a $16 price target, raised from $14, at Piper Jaffray, which says the company's story has improved with the equity offering and non-core asset sales.</li>     <li>Jaffray cites MRO's improved financial resilience, meaningful operational leverage to ongoing oil price appreciation, a well rounded U.S. unconventional portfolio with exposure to the emerging SCOOP and STACK plays, and reasonable relative valuation.</li>     <li>The firm says Suncor Energy remains its top pick among major oil companies, with 40% upside potential to its $40 price target.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3186342\" data-linked=\"Marathon Oil upped to Outperform at Piper Jaffray\" data-tweet=\"$MRO - Marathon Oil upped to Outperform at Piper Jaffray https://seekingalpha.com/news/3186342-marathon-oil-upped-to-outperform-piper-jaffray?source=tweet\" data-url=\"https://seekingalpha.com/news/3186342-marathon-oil-upped-to-outperform-piper-jaffray\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186329\" data-ts=\"1464700676\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLF\" target=\"_blank\">CLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186329-cliffs-natural-resourcesplus-30-j-p-morgan-upgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cliffs Natural Resources +30% as J.P. Morgan upgrades</a></h4><ul>\n<li>Cliffs Natural Resources (NYSE:<a href=\"https://seekingalpha.com/symbol/CLF\" title=\"Cleveland-Cliffs, Inc.\">CLF</a>) <font color=\"green\">+29.8%</font> premarket after J.P. Morgan <a href=\"http://business.financialpost.com/investing/trading-desk/cliffs-natural-resources-inc-upgraded-to-overweight\" target=\"_blank\">upgrades</a> shares to Overweight from Neutral with a $7 price target, as the firm expects rising steel prices to generate much higher near-term earnings growth.</li>\n<li>JPM's Michael Gambardella says he is confident that CLF's steel pellet supply contracts with ArcelorMittal - CLF's largest customer - that are expiring near the end of this year will be renewed favorably.</li>\n<li>The analyst notes that CLF management's guidance still assumes a hot rolled coil steel price of $450/metric ton vs. the current spot price of ~$610.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3186329\" data-linked=\"Cliffs Natural Resources +30% as J.P. Morgan upgrades\" data-tweet=\"$CLF - Cliffs Natural Resources +30% as J.P. Morgan upgrades https://seekingalpha.com/news/3186329-cliffs-natural-resourcesplus-30-j-p-morgan-upgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/3186329-cliffs-natural-resourcesplus-30-j-p-morgan-upgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>32&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186327\" data-ts=\"1464700508\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186327-premarket-gainers-losers-of-9-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:10 am</a></h4><ul> <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CPXX' title='Celator Pharmaceuticals, Inc.'>CPXX</a> <font color='green'>+71%</font>. <a href='https://seekingalpha.com/symbol/SQI' title='SciQuest, Inc.'>SQI</a> <font color='green'>+32%</font>. <a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs, Inc.'>CLF</a> <font color='green'>+31%</font>. <a href='https://seekingalpha.com/symbol/BOSC' title='B.O.S. Better Online Solutions'>BOSC</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/CBAY' title='CymaBay Therapeutics'>CBAY</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/TTM' title='Tata Motors Limited'>TTM</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/SODA' title='SodaStream International'>SODA</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/CLRB' title='Cellectar Biosciences, Inc.'>CLRB</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/CIE' title='Cobalt International Energy, Inc.'>CIE</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/WR' title='Westar Energy, Inc.'>WR</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/NERV' title='Minerva Neurosciences'>NERV</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/FOLD' title='Amicus Therapeutics, Inc.'>FOLD</a> <font color='green'>+6%</font>.</li> <li><b>Losers:</b> STEM <font color='red'>-81%</font>. <a href='https://seekingalpha.com/symbol/CCE-OLD' title='Coca-Cola European Partners plc'>CCE-OLD</a> <font color='red'>-27%</font>. <a href='https://seekingalpha.com/symbol/GXP' title='Great Plains Energy Inc.'>GXP</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/MUX' title='McEwen Mining Inc.'>MUX</a> <font color='red'>-5%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3186327\" data-linked=\"Premarket Gainers / Losers as of 9:10 am\" data-tweet=\"$CPXX $SQI $CLF - Premarket Gainers / Losers as of 9:10 am https://seekingalpha.com/news/3186327-premarket-gainers-losers-of-9-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3186327-premarket-gainers-losers-of-9-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186301\" data-ts=\"1464697238\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEVA\" target=\"_blank\">TEVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186301-teva-receives-crl-in-response-to-sdminus-809-nda\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teva receives CRL in response to SD-809 NDA</a></h4><ul>\n<li>Teva Pharmaceutical Industries (NYSE:<a href=\"https://seekingalpha.com/symbol/TEVA\" title=\"Teva Pharmaceutical Industries Limited\">TEVA</a>) is down <font color=\"red\">2%</font> premarket on increased volume in response to its <a href=\"https://www.sec.gov/Archives/edgar/data/818686/000130901416001136/exhibit1.htm\" target=\"_blank\">announcement </a>that it received a Complete Response Letter (CRL) from the FDA regarding its New Drug Application (NDA) seeking approval of SD-809 for the treatment of <a href=\"https://en.wikipedia.org/wiki/Chorea\" target=\"_blank\">chorea </a>(involuntary movements) associated with <a href=\"http://www.mayoclinic.org/diseases-conditions/huntingtons-disease/basics/definition/con-20030685\" target=\"_blank\">Huntington's disease</a>, an inherited disorder characterized by the progressive breakdown of nerve cells that leads to movement, cognitive and psychiatric problems.</li>\n<li>The agency did not request additional clinical trials but wanted the company to re-analyze blood levels of certain metabolites. Teva intends to address the issue as soon as possible and submit its response in Q3.</li>\n<li>\n<a href=\"http://www.auspexpharma.com/wp-content/uploads/2013/12/D-Stamler-Auspex-HDSA-2013-0621-FINAL.pdf\" target=\"_blank\">SD-809</a> (deutetrabenazine) is an orally available small molecule inhibitor of vesicular monoamine 2 transporter (VMAT2) that is designed to regulate the levels of the neurotransporter dopamine in the brain.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3186301\" data-linked=\"Teva receives CRL in response to SD-809 NDA\" data-tweet=\"$TEVA - Teva receives CRL in response to SD-809 NDA https://seekingalpha.com/news/3186301-teva-receives-crl-in-response-to-sdminus-809-nda?source=tweet\" data-url=\"https://seekingalpha.com/news/3186301-teva-receives-crl-in-response-to-sdminus-809-nda\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186272\" data-ts=\"1464693267\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GXP\" target=\"_blank\">GXP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186272-great-plains-energy-to-buy-westar-energy-for-8_6b\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Great Plains Energy to buy Westar Energy for $8.6B</a></h4><ul>     <li>Great Plains Energy (NYSE:<a href=\"https://seekingalpha.com/symbol/GXP\" title=\"Great Plains Energy Inc.\">GXP</a>) agrees to acquire Westar Energy (NYSE:<a href=\"https://seekingalpha.com/symbol/WR\" title=\"Westar Energy, Inc.\">WR</a>) for $8.6B in cash  and stock, in a <a href=\"http://www.wsj.com/articles/great-plains-energy-to-buy-westar-energy-for-8-6-billion-1464691927\" target=\"_blank\">major consolidation</a> in the utilities sector.</li>     <li>WR shareholders will receive $60/share - $51 in cash and $9 in GXP stock - a 13% premium to WR's closing price on Friday.</li>     <li>The companies say the enterprise value of the deal is ~$12.2B, including WR's ~$3.6B of debt.</li>     <li>GXP CEO Terry Bassham will be chairman and CEO of the combined company.</li>     <li>Upon completion of the deal, GXP, the  parent of Kansas City Power &amp; Light, will have more than 1.5M customers in Kansas and Missouri.</li>\n<li>WR <font color=\"green\">+8.9%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3186272\" data-linked=\"Great Plains Energy to buy Westar Energy for $8.6B\" data-tweet=\"$GXP $GXP $WR - Great Plains Energy to buy Westar Energy for $8.6B https://seekingalpha.com/news/3186272-great-plains-energy-to-buy-westar-energy-for-8_6b?source=tweet\" data-url=\"https://seekingalpha.com/news/3186272-great-plains-energy-to-buy-westar-energy-for-8_6b\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186262\" data-ts=\"1464692497\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ICPT\" target=\"_blank\">ICPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186262-fda-oks-intercepts-oca-for-type-of-liver-disease-shares-up-14-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs Intercept&#39;s OCA for type of liver disease; shares up 14% premarket</a></h4><ul>\n<li>As expected, the FDA grants accelerated approval for Intercept Pharmaceuticals' (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ICPT\" title=\"Intercept Pharmaceuticals\">ICPT</a>) Ocaliva (obeticholic acid) (OCA), in combination with <a href=\"https://en.wikipedia.org/wiki/Ursodeoxycholic_acid\" target=\"_blank\">ursodeoxycholic acid</a> (UDCA), for the treatment of <a href=\"http://www.mayoclinic.org/diseases-conditions/primary-biliary-cirrhosis/basics/definition/con-20029377\" target=\"_blank\">primary biliary cholangitis</a>, formerly known as primary biliary cirrhosis, an autoimmune disease in which the bile ducts in the liver are slowly destroyed.</li>\n<li>Ocaliva is approved in combination with UDCA in patients who have not responded adequately to UDCA or as monotherapy in patients who cannot tolerate UDCA.</li>\n<li>In early April, the FDA's Gastrointestinal Drugs Advisory Committee voted 17-0 backing approval.</li>\n<li>OCA is an agonist of the farnesoid X receptor, a nuclear receptor expressed in the liver and intestine that is a key regulator of bile acid, inflammatory, fibrotic and metabolic pathways.</li>\n<li>Intercept is up <font color=\"green\">14%</font> premarket on light volume.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3172163-intercept-pharma-5-percent-premarket-positive-ad-comm-vote\" target=\"_blank\">Intercept Pharma up 5% premarket after positive Ad Comm vote</a> (April 8)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3186262\" data-linked=\"FDA OKs Intercept&#39;s OCA for type of liver disease; shares up 14% premarket\" data-tweet=\"$ICPT - FDA OKs Intercept&#39;s OCA for type of liver disease; shares up 14% premarket https://seekingalpha.com/news/3186262-fda-oks-intercepts-oca-for-type-of-liver-disease-shares-up-14-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3186262-fda-oks-intercepts-oca-for-type-of-liver-disease-shares-up-14-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186260\" data-ts=\"1464692249\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NPD\" target=\"_blank\">NPD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186260-on-china-nepstar-chain-drugstores-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on China Nepstar Chain Drugstore&#39;s Q1</a></h4><ul>     <li>China Nepstar Chain Drugstore (NYSE:<a href=\"https://seekingalpha.com/symbol/NPD\" title=\"China Nepstar Chain Drugstore Ltd.\">NPD</a>) reports comparable-store sales rose 9.8% in Q1 primarily due to increased in-store promotional initiatives and improved marketing of pharmaceutical products.</li>     <li>Revenue contribution by products: Prescription drugs 24.4%; OTC 45.4%; Nutritional supplements 10.5%; Herbal products 5.1%; Convenience and other products 14.6%.</li>     <li>Private label products sales represents ~14% of the total revenue &amp; 20.6% of the gross profit.</li>     <li>Gross margin rate improved 120 bps to 42% due to a better product mix.</li>     <li>Inventory expanded 2.6% Y/Y to $91.8M.</li>     <li>Store count +31 Y/Y to 2,000.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3186260\" data-linked=\"More on China Nepstar Chain Drugstore&#39;s Q1\" data-tweet=\"$NPD - More on China Nepstar Chain Drugstore&#39;s Q1 https://seekingalpha.com/news/3186260-on-china-nepstar-chain-drugstores-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3186260-on-china-nepstar-chain-drugstores-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3186215\" data-ts=\"1464680979\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JAZZ\" target=\"_blank\">JAZZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3186215-jazz-pharmas-deal-for-celator-come-today\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jazz Pharma&#39;s deal for Celator could come today</a></h4><ul>\n<li>Jazz Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/JAZZ\" title=\"Jazz Pharmaceuticals, Inc.\">JAZZ</a>) is nearing a deal to <a href=\"http://www.wsj.com/articles/jazz-pharmaceuticals-nears-deal-to-buy-celator-for-about-1-5-billion-1464660528?mod=wsj_nview_latest\" target=\"_blank\">buy</a> Celator (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CPXX\" title=\"Celator Pharmaceuticals, Inc.\">CPXX</a>) for $1.5B, or about double its market cap - a huge premium even in biotechnology, where acquirers often pay for promising new drugs.</li>\n<li>About three months ago, Celator said its Vyxeos treatment helped older high-risk patients with a deadly form of leukemia live longer than those who received the standard of care regimen, sending its stock price soaring.</li>\n<li>CPXX <font color=\"green\">+78.3%</font> premarket</li>\n<li>\n<strong>Update</strong>: Jazz announces that it will acquire Celator for $30.25 per share in cash or ~$1.5B.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3186215\" data-linked=\"Jazz Pharma&#39;s deal for Celator could come today\" data-tweet=\"$JAZZ $JAZZ $CPXX - Jazz Pharma&#39;s deal for Celator could come today https://seekingalpha.com/news/3186215-jazz-pharmas-deal-for-celator-come-today?source=tweet\" data-url=\"https://seekingalpha.com/news/3186215-jazz-pharmas-deal-for-celator-come-today\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":49,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}